Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Analytical Chemistry

Paul G. Allen launches biomedical research fund

by Lisa M. Jarvis
March 28, 2016 | A version of this story appeared in Volume 94, Issue 13

Microsoft cofounder Paul G. Allen is putting $100 million into the formation of the Paul G. Allen Frontiers Group, a mechanism for supporting risky, but potentially groundbreaking, biomedical research projects. The first two Allen Discovery Centers will receive on average $20 million in funding over eight years. Stanford University will create computer models to understand how bacteria infect macrophages, and a project at Tufts University will focus on elucidating how complex organ systems are created and repaired. The Frontiers Group also announced four Allen Distinguished Investigators, academic researchers who will each receive grants worth up to $1.5 million.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.